Related Experiment Video
Updated: Jan 26, 2026

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells
Rehana L Ahmed1,2, Daniel P Shaughnessy3, Todd P Knutson4,5
1Department of Dermatology, University of Minnesota, Minneapolis, MN 55455, USA. ahme0056@umn.edu.
Abstract:
Cyclin dependent kinase 11 (CDK11) is a protein kinase that regulates RNA transcription, pre-mRNA splicing, mitosis, and cell death. Targeting of CDK11 expression levels is effective in the experimental treatment of breast and other cancers, but these data are lacking in melanoma. To understand CDK11 function in melanoma, we evaluated protein and RNA levels of CDK11, Cyclin L1 and Cyclin L2 in benign melanocytes and BRAF- as well as NRAS-mutant melanoma cell lines. We investigated the effectiveness of reducing expression of this survival kinase using RNA interference on viability, clonal survival, and tumorsphere formation in melanoma cell lines. We examined the impact of CDK11 loss in BRAF-mutant melanoma on more than 700 genes important in cancer signaling pathways. Follow-up analysis evaluated how CDK11 loss alters cell cycle function in BRAF- and NRAS-mutant melanoma cells. We present data on CDK11, CCNL1 and CCNL2 mRNA expression in melanoma patients, including prognosis for survival. In sum, we found that CDK11 is necessary for melanoma cell survival, and a major impact of CDK11 loss in melanoma is to cause disruption of the cell cycle distribution with accumulation of G1- and loss of G2/M-phase cancer cells.
Insights
Cyclin dependent kinase 11 (CDK11) is crucial for melanoma cell survival. Reducing CDK11 disrupts the cell cycle, impacting cancer cell proliferation and offering potential therapeutic strategies for melanoma.
Area of Science:
- Molecular biology
- Cancer research
- Cell biology
Background:
- Cyclin dependent kinase 11 (CDK11) regulates key cellular processes including transcription and mitosis.
- CDK11's role in melanoma is understudied, despite its therapeutic potential in other cancers.
- Understanding CDK11 function is vital for developing new melanoma treatments.
Purpose of the Study:
- To investigate the function and expression of CDK11 in melanoma.
- To evaluate the therapeutic potential of targeting CDK11 in melanoma cell lines.
- To analyze the impact of CDK11 loss on cancer signaling pathways and cell cycle progression.
Main Methods:
- Assessed CDK11, Cyclin L1, and Cyclin L2 protein and RNA levels in melanocytes and melanoma cell lines.
- Utilized RNA interference to reduce CDK11 expression and evaluated effects on cell viability and survival.
- Examined gene expression changes and cell cycle distribution following CDK11 knockdown in melanoma cells.
Main Results:
- CDK11 is essential for melanoma cell survival.
- Reducing CDK11 expression significantly impairs melanoma cell viability, clonal survival, and tumorsphere formation.
- CDK11 loss disrupts cell cycle distribution, causing G1-phase accumulation and G2/M-phase loss.
Conclusions:
- CDK11 is a critical survival kinase in melanoma.
- Targeting CDK11 presents a promising therapeutic strategy for melanoma treatment.
- CDK11 inhibition profoundly impacts melanoma cell cycle regulation and proliferation.
Related Concept Videos
What is the Cell Cycle?
What is the Cell Cycle?
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System

